This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


Introduction: Atypical Antipsychotics in the Treatment of Children and Adolescents

Robert L. Findling, MD

Published: April 1, 2004

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Antipsychotic drugs are commonly used in children and adolescents for a variety of psychiatric conditions. Although the conventional antipsychotics have proved effective in the pediatric population,1,2 their use is limited by safety concerns, such as extrapyramidal symptoms, for which the risk is higher in children than in adults, and possible adverse effects on cognition.1

Compared with conventional antipsychotics, atypical antipsychotics are less likely to cause extrapyramidal symptoms in young people.3‘ ‹’ ‹

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 65

Quick Links: Child and Adolescent , Populations

Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...